Feb 19, 2010 | Digital Pathology, Laboratory News, Laboratory Pathology
Mass General researchers use metabolomic imaging to accurately diagnose tumors Pathology laboratories may soon find it possible to identify prostate cancer without a biopsy. A new technology under development at Massachusetts General Hospital demonstrates the potential to improve the accuracy of prostate cancer diagnosis. Some studies have demonstrated that nearly a quarter of initial biopsies of the prostate gland may generate false-negative results because the biopsy specimen failed to...
